サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1477982

除細動器市場：地域別（北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカ）：世界の産業分析、規模、シェア、成長、動向、2024-2032年予測

Defibrillator Market by Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

出版日
ページ情報
英文 250 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.76円
除細動器市場：地域別（北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカ）：世界の産業分析、規模、シェア、成長、動向、2024-2032年予測
出版日: 2024年05月03日
発行: Persistence Market Research
ページ情報: 英文 250 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

除細動器市場レポートは、2024年から2032年までの期間における主要なダイナミクス、成長要因、課題、新興動向などを網羅し、業界の詳細な分析を提供します。本レポートは、世界の除細動器市場の現在のシナリオと将来予測に関する洞察を提供します。

除細動器の世界市場は、2024年の122億米ドルからCAGR（複合年間成長率）7.4%で成長し、2032年には249億米ドルに達すると予測されます。

主な洞察

  • 推定市場規模（2024年）：122億米ドル
  • 予測市場規模（2032年）：249億米ドル
  • 世界市場成長率（CAGR 2024年～2032年）：7.4%

除細動器市場：調査範囲

除細動器は、突然の心停止（SCA）の治療に使用される重要な医療機器です。治療量の電気エネルギーを患部の心臓に供給します。本レポートでは、除細動器需要の主な促進要因として、心血管疾患の罹患率の増加、人命救助における早期除細動の重要性に関する一般市民の意識の高まり、除細動器技術の進歩などを概説しています。

市場成長の促進要因：

除細動器市場の成長にはいくつかの要因が寄与しています。主な促進要因は、突然の心停止のリスクを増大させる心血管疾患の世界の有病率の上昇です。さらに、空港、学校、スポーツ競技場などの公共空間に自動体外式除細動器（AED）を設置する公共アクセス除細動プログラムの拡大も大きな成長促進要因です。除細動器をより使いやすく効果的にする技術の進歩も、市場拡大を後押ししています。さらに、医療従事者以外の人々にAEDの使用方法を教育する政府の取り組みや、公共の場での除細動器の利用を義務付ける厳しい規制の実施も、市場の成長を後押ししています。

市場の抑制要因：

見通しは明るいもの、除細動器市場は課題に直面しています。高度な除細動器システムに関連する高コストは、特に低開発地域や新興国市場における市場成長の妨げとなる可能性があります。また、除細動器のメンテナンスや交換に関する課題も、さらなる課題となっています。承認のための規制上のハードルや、機器の誤動作や故障に関する懸念も、市場の成長を阻害する可能性があります。

市場機会：

除細動器市場には、成長と技術革新のための大きな機会があります。主要な機会の1つは、患者のニーズによりよく対応できる、より高度な植え込み型除細動器（ICD）やウェアラブル除細動器の開発にあります。農村部や十分なサービスを受けていない地域にAEDを普及させることも、成長の道となります。さらに、公的機関と非公開会社の協力関係を強化することで、一般市民の認知度向上やトレーニングプログラムの充実が図られ、市場はさらに拡大する可能性があります。

本レポートで扱う主な質問

  • 2024年から2032年までの除細動器世界市場の予想CAGRは？
  • 除細動器市場の成長を促進する主な要因は何か？
  • 除細動器市場で最大の市場シェアを占める製品タイプは？
  • 除細動器の世界市場における主要プレイヤーは？
  • 除細動器市場で競合を維持するために主要企業はどのような戦略を採用しているか？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/分類
  • 市場の定義/範囲/制限

第3章 市場背景

  • 市場力学
  • シナリオ予測
  • 機会マップ分析
  • 製品ライフサイクル分析
  • サプライチェーン分析
  • 投資実現可能性マトリックス
  • バリューチェーン分析
  • PESTLEとポーター分析
  • 規制状況
  • 地域親市場見通し
  • 生産・消費統計
  • 輸入と輸出の統計

第4章 世界の除細動器市場分析

  • 過去の市場規模（金額および数量）分析、2019-2023年
  • 現在および将来の市場規模（金額および数量）予測、2024～2032年

第5章 世界の除細動器市場分析：製品タイプ別

  • イントロダクション/主な調査結果
  • 過去の市場規模（金額および数量）分析、2019-2023年
  • 現在および将来の市場規模（金額および数量）分析および予測、2024-2032年
    • 植込み型除細動器（ICD）
      • S-ICD
      • T-ICD
    • 体外式除細動器（ED）
      • マニュアルED
      • 自動ED
      • ウェアラブル除細動器
  • 前年比成長動向分析、2019～2023年
  • 絶対的収益の機会分析、2024～2032年

第6章 世界除細動器市場分析：エンドユーザー別

  • イントロダクション/主な調査結果
  • 過去の市場規模（金額および数量）分析、2019-2023年
  • 現在および将来の市場規模（金額および数量）分析および予測、2024-2032年
    • 病院
    • 病院前
    • パブリックアクセスマーケット
    • 代替ケア市場
    • 在宅ヘルスケア
  • 前年比成長動向分析、2019～2023年
  • 絶対的収益の機会分析、2024～2032年

第7章 世界除細動器市場分析：地域別

  • イントロダクション
  • 過去の市場規模（金額および数量）分析、2019-2023年
  • 現在の市場規模（金額および数量）分析および予測、2024-2032年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ
  • 地域別市場魅力度分析

第8章 北米の除細動器市場分析（国別）

第9章 ラテンアメリカの除細動器市場分析（国別）

第10章 欧州の除細動器市場分析（国別）

第11章 東アジアの除細動器市場分析（国別）

第12章 南アジアの除細動器市場分析（国別）

第13章 オセアニア除細動器市場分析（国別）

第14章 中東・アフリカの除細動器市場分析（国別）

第15章 主要国の除細動器市場分析

  • 米国
  • カナダ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • ドイツ
  • イタリア
  • フランス
  • 英国
  • スペイン
  • ロシア
  • ベネルクス
  • 中国
  • 日本
  • 韓国
  • インド
  • タイ
  • マレーシア
  • インドネシア
  • オーストラリア
  • ニュージーランド
  • GCC諸国

第16章 市場構造分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 主要企業の市場シェア分析

第17章 競合分析

  • 競合の詳細
    • Medtronic
    • Abbott
    • Boston Scientific Corporation
    • Stryker
    • Zoll Medical Corporation
    • Biotronik
    • Nihon Kohden Corporation
    • METRAWATT International
    • Datrend Systems
    • Fluke
    • BC Group International
    • Netech

第18章 使用される前提条件と頭字語

第19章 調査手法

目次
Product Code: PMRREP33203

The Defibrillator Market report provides a detailed analysis of the industry, covering key dynamics, growth factors, challenges, and emerging trends for the period from 2024 to 2032. This report offers insights into the current scenario and future projections of the global defibrillator market.

The global defibrillator market is projected to grow at a compound annual growth rate (CAGR) of 7.4% from USD 12.2 billion in 2024 to USD 24.9 billion by 2032.

Key Insights:

  • Estimated Market Size (2024): USD 12.2 Billion
  • Projected Market Size (2032): USD 24.9 Billion
  • Global Market Growth Rate (CAGR 2024 to 2032): 7.4%

Defibrillator Market - Report Scope:

Defibrillators are critical medical devices used in the treatment of sudden cardiac arrest (SCA). They deliver a therapeutic dose of electrical energy to the affected heart. The report outlines key drivers of demand for defibrillators, including increasing incidence of cardiovascular diseases, growing public awareness about the importance of early defibrillation in saving lives, and advancements in defibrillator technology.

Market Growth Drivers:

Several factors contribute to the growth of the defibrillator market. The primary driver is the rising prevalence of cardiovascular diseases globally, which increases the risk of sudden cardiac arrest. Additionally, the expansion of public access defibrillation programs, which involve placing automated external defibrillators (AEDs) in public spaces like airports, schools, and sports arenas, is another significant growth driver. Technological advancements in defibrillators, making them more user-friendly and effective, also support market expansion. Furthermore, government initiatives to train non-medical personnel in the use of AEDs and the implementation of stringent regulations mandating the availability of defibrillators in public places enhance market growth.

Market Restraints:

Despite the positive outlook, the defibrillator market faces challenges. High costs associated with advanced defibrillator systems can hinder market growth, particularly in underdeveloped and developing regions. Also, issues related to the maintenance and replacement of these devices pose additional challenges. Regulatory hurdles for approval and concerns about device malfunction or failure can also impede market growth.

Market Opportunities:

The defibrillator market offers significant opportunities for growth and innovation. One major opportunity lies in the development of more sophisticated implantable cardioverter defibrillators (ICDs) and wearable defibrillator devices that can better cater to patient needs. Expanding the reach of AEDs into rural and underserved areas presents another growth avenue. Additionally, increasing collaborations between public organizations and private companies to enhance public awareness and training programs can further expand the market.

Key Questions Addressed in the Report:

  • What is the Expected CAGR of the Global Defibrillator Market from 2024 to 2032?
  • What are the Key Factors Driving the Growth of the Defibrillator Market?
  • Which Product Type Holds the Largest Market Share in the Defibrillator Market?
  • Who are the Key Players in the Global Defibrillator Market?
  • What Strategies are Adopted by Leading Companies to Stay Competitive in the Defibrillator Market?

Competitive Landscape and Business Strategies:

The key players in the Defibrillator Market include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Koninklijke Philips N.V., and ZOLL Medical Corporation, among others. These companies focus on innovation, such as integrating advanced monitoring technologies with defibrillators, to maintain their market position. Strategic partnerships and acquisitions are also commonly pursued to expand product lines and geographic presence.

Key Companies Profiled

  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Stryker
  • Zoll Medical Corporation
  • Biotronik
  • Nihon Kohden Corporation
  • METRAWATT International
  • Datrend Systems
  • Fluke
  • BC Group International
  • Netech

Market Segments Covered in Defibrillator Market Analysis

By Component

  • Implantable Cardioverter Defibrillators (ICD)
  • External Defibrillators (ED)

By Type

  • S-ICD
  • T-ICD
  • Manual ED
  • Automated ED
  • Wearable Cardioverter Defibrillators

By End Use

  • Hospital
  • Pre Hospital
  • Public Access Market
  • Alternate Care Market
  • Home Healthcare

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Product Life Cycle Analysis
  • 3.5. Supply Chain Analysis
    • 3.5.1. Supply Side Participants and their Roles
      • 3.5.1.1. Producers
    • 3.5.2. Value Added and Value Created at Node in the Supply Chain
    • 3.5.3. List of Existing and Potential Buyer's
  • 3.6. Investment Feasibility Matrix
  • 3.7. Value Chain Analysis
    • 3.7.1. Profit Margin Analysis
  • 3.8. PESTLE and Porter's Analysis
  • 3.9. Regulatory Landscape
    • 3.9.1. By Key Regions
    • 3.9.2. By Key Countries
  • 3.10. Regional Parent Market Outlook
  • 3.11. Production and Consumption Statistics
  • 3.12. Import and Export Statistics

4. Global Defibrillator Market Analysis 2019-2023 and Forecast, 2024-2032

  • 4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2024-2032
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Product Type

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product Type, 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product Type, 2024-2032
    • 5.3.1. Implantable Cardioverter Defibrillators (ICD)
      • 5.3.1.1. S-ICD
      • 5.3.1.2. T-ICD
    • 5.3.2. External Defibrillators (ED)
      • 5.3.2.1. Manual ED
      • 5.3.2.2. Automated ED
      • 5.3.2.3. Wearable Cardioverter Defibrillators
  • 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Product Type, 2024-2032

6. Global Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By End User

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End User, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End User, 2024-2032
    • 6.3.1. Hospital
    • 6.3.2. Pre Hospital
    • 6.3.3. Public Access Market
    • 6.3.4. Alternate Care Market
    • 6.3.5. Home Healthcare
  • 6.4. Y-o-Y Growth Trend Analysis By End User, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By End User, 2024-2032

7. Global Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 7.1. Introduction
  • 7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2019-2023
  • 7.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2024-2032
    • 7.3.1. North America
    • 7.3.2. Latin America
    • 7.3.3. Europe
    • 7.3.4. East Asia
    • 7.3.5. South Asia
    • 7.3.6. Oceania
    • 7.3.7. MEA
  • 7.4. Market Attractiveness Analysis By Region

8. North America Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 8.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 8.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2032
    • 8.2.1. By Country
      • 8.2.1.1. U.S.
      • 8.2.1.2. Canada
    • 8.2.2. By Product Type
    • 8.2.3. By End User
  • 8.3. Market Attractiveness Analysis
    • 8.3.1. By Country
    • 8.3.2. By Product Type
    • 8.3.3. By End User
  • 8.4. Key Takeaways

9. Latin America Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2032
    • 9.2.1. By Country
      • 9.2.1.1. Brazil
      • 9.2.1.2. Mexico
      • 9.2.1.3. Argentina
      • 9.2.1.4. Rest of Latin America
    • 9.2.2. By Product Type
    • 9.2.3. By End User
  • 9.3. Market Attractiveness Analysis
    • 9.3.1. By Country
    • 9.3.2. By Product Type
    • 9.3.3. By End User
  • 9.4. Key Takeaways

10. Europe Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2032
    • 10.2.1. By Country
      • 10.2.1.1. Germany
      • 10.2.1.2. Italy
      • 10.2.1.3. France
      • 10.2.1.4. U.K.
      • 10.2.1.5. Spain
      • 10.2.1.6. Russia
      • 10.2.1.7. BENELUX
      • 10.2.1.8. Rest of Europe
    • 10.2.2. By Product Type
    • 10.2.3. By End User
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Product Type
    • 10.3.3. By End User
  • 10.4. Key Takeaways

11. East Asia Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2032
    • 11.2.1. By Country
      • 11.2.1.1. China
      • 11.2.1.2. Japan
      • 11.2.1.3. South Korea
    • 11.2.2. By Product Type
    • 11.2.3. By End User
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Product Type
    • 11.3.3. By End User
  • 11.4. Key Takeaways

12. South Asia Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2032
    • 12.2.1. By Country
      • 12.2.1.1. India
      • 12.2.1.2. Thailand
      • 12.2.1.3. Malaysia
      • 12.2.1.4. Indonesia
      • 12.2.1.5. Rest of South Asia
    • 12.2.2. By Product Type
    • 12.2.3. By End User
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Product Type
    • 12.3.3. By End User
  • 12.4. Key Takeaways

13. Oceania Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2032
    • 13.2.1. By Country
      • 13.2.1.1. Australia
      • 13.2.1.2. New Zealand
    • 13.2.2. By Product Type
    • 13.2.3. By End User
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Product Type
    • 13.3.3. By End User
  • 13.4. Key Takeaways

14. MEA Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 14.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2032
    • 14.2.1. By Country
      • 14.2.1.1. GCC
      • 14.2.1.2. Rest of MEA
    • 14.2.2. By Product Type
    • 14.2.3. By End User
  • 14.3. Market Attractiveness Analysis
    • 14.3.1. By Country
    • 14.3.2. By Product Type
    • 14.3.3. By End User
  • 14.4. Key Takeaways

15. Key Countries Defibrillator Market Analysis

  • 15.1. U.S.
    • 15.1.1. Pricing Analysis
    • 15.1.2. Market Share Analysis, 2024
      • 15.1.2.1. By Product Type
      • 15.1.2.2. By End User
  • 15.2. Canada
    • 15.2.1. Pricing Analysis
    • 15.2.2. Market Share Analysis, 2024
      • 15.2.2.1. By Product Type
      • 15.2.2.2. By End User
  • 15.3. Brazil
    • 15.3.1. Pricing Analysis
    • 15.3.2. Market Share Analysis, 2024
      • 15.3.2.1. By Product Type
      • 15.3.2.2. By End User
  • 15.4. Mexico
    • 15.4.1. Pricing Analysis
    • 15.4.2. Market Share Analysis, 2024
      • 15.4.2.1. By Product Type
      • 15.4.2.2. By End User
  • 15.5. Argentina
    • 15.5.1. Pricing Analysis
    • 15.5.2. Market Share Analysis, 2024
      • 15.5.2.1. By Product Type
      • 15.5.2.2. By End User
  • 15.6. Germany
    • 15.6.1. Pricing Analysis
    • 15.6.2. Market Share Analysis, 2024
      • 15.6.2.1. By Product Type
      • 15.6.2.2. By End User
  • 15.7. Italy
    • 15.7.1. Pricing Analysis
    • 15.7.2. Market Share Analysis, 2024
      • 15.7.2.1. By Product Type
      • 15.7.2.2. By End User
  • 15.8. France
    • 15.8.1. Pricing Analysis
    • 15.8.2. Market Share Analysis, 2024
      • 15.8.2.1. By Product Type
      • 15.8.2.2. By End User
  • 15.9. U.K.
    • 15.9.1. Pricing Analysis
    • 15.9.2. Market Share Analysis, 2024
      • 15.9.2.1. By Product Type
      • 15.9.2.2. By End User
  • 15.10. Spain
    • 15.10.1. Pricing Analysis
    • 15.10.2. Market Share Analysis, 2024
      • 15.10.2.1. By Product Type
      • 15.10.2.2. By End User
  • 15.11. Russia
    • 15.11.1. Pricing Analysis
    • 15.11.2. Market Share Analysis, 2024
      • 15.11.2.1. By Product Type
      • 15.11.2.2. By End User
  • 15.12. BENELUX
    • 15.12.1. Pricing Analysis
    • 15.12.2. Market Share Analysis, 2024
      • 15.12.2.1. By Product Type
      • 15.12.2.2. By End User
  • 15.13. China
    • 15.13.1. Pricing Analysis
    • 15.13.2. Market Share Analysis, 2024
      • 15.13.2.1. By Product Type
      • 15.13.2.2. By End User
  • 15.14. Japan
    • 15.14.1. Pricing Analysis
    • 15.14.2. Market Share Analysis, 2024
      • 15.14.2.1. By Product Type
      • 15.14.2.2. By End User
  • 15.15. South Korea
    • 15.15.1. Pricing Analysis
    • 15.15.2. Market Share Analysis, 2024
      • 15.15.2.1. By Product Type
      • 15.15.2.2. By End User
  • 15.16. India
    • 15.16.1. Pricing Analysis
    • 15.16.2. Market Share Analysis, 2024
      • 15.16.2.1. By Product Type
      • 15.16.2.2. By End User
  • 15.17. Thailand
    • 15.17.1. Pricing Analysis
    • 15.17.2. Market Share Analysis, 2024
      • 15.17.2.1. By Product Type
      • 15.17.2.2. By End User
  • 15.18. Malaysia
    • 15.18.1. Pricing Analysis
    • 15.18.2. Market Share Analysis, 2024
      • 15.18.2.1. By Product Type
      • 15.18.2.2. By End User
  • 15.19. Indonesia
    • 15.19.1. Pricing Analysis
    • 15.19.2. Market Share Analysis, 2024
      • 15.19.2.1. By Product Type
      • 15.19.2.2. By End User
  • 15.20. Australia
    • 15.20.1. Pricing Analysis
    • 15.20.2. Market Share Analysis, 2024
      • 15.20.2.1. By Product Type
      • 15.20.2.2. By End User
  • 15.21. New Zealand
    • 15.21.1. Pricing Analysis
    • 15.21.2. Market Share Analysis, 2024
      • 15.21.2.1. By Product Type
      • 15.21.2.2. By End User
  • 15.22. GCC Countries
    • 15.22.1. Pricing Analysis
    • 15.22.2. Market Share Analysis, 2024
      • 15.22.2.1. By Product Type
      • 15.22.2.2. By End User

16. Market Structure Analysis

  • 16.1. Competition Dashboard
  • 16.2. Competition Benchmarking
  • 16.3. Market Share Analysis of Top Players
    • 16.3.1. By Regional
    • 16.3.2. By Product Type
    • 16.3.3. By End User

17. Competition Analysis

  • 17.1. Competition Deep Dive
    • 17.1.1. Medtronic
      • 17.1.1.1. Overview
      • 17.1.1.2. Product Portfolio
      • 17.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.1.4. Sales Footprint
      • 17.1.1.5. Strategy Overview
        • 17.1.1.5.1. Marketing Strategy
        • 17.1.1.5.2. Product Strategy
        • 17.1.1.5.3. Channel Strategy
    • 17.1.2. Abbott
      • 17.1.2.1. Overview
      • 17.1.2.2. Product Portfolio
      • 17.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.2.4. Sales Footprint
      • 17.1.2.5. Strategy Overview
        • 17.1.2.5.1. Marketing Strategy
        • 17.1.2.5.2. Product Strategy
        • 17.1.2.5.3. Channel Strategy
    • 17.1.3. Boston Scientific Corporation
      • 17.1.3.1. Overview
      • 17.1.3.2. Product Portfolio
      • 17.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.3.4. Sales Footprint
      • 17.1.3.5. Strategy Overview
        • 17.1.3.5.1. Marketing Strategy
        • 17.1.3.5.2. Product Strategy
        • 17.1.3.5.3. Channel Strategy
    • 17.1.4. Stryker
      • 17.1.4.1. Overview
      • 17.1.4.2. Product Portfolio
      • 17.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.4.4. Sales Footprint
      • 17.1.4.5. Strategy Overview
        • 17.1.4.5.1. Marketing Strategy
        • 17.1.4.5.2. Product Strategy
        • 17.1.4.5.3. Channel Strategy
    • 17.1.5. Zoll Medical Corporation
      • 17.1.5.1. Overview
      • 17.1.5.2. Product Portfolio
      • 17.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.5.4. Sales Footprint
      • 17.1.5.5. Strategy Overview
        • 17.1.5.5.1. Marketing Strategy
        • 17.1.5.5.2. Product Strategy
        • 17.1.5.5.3. Channel Strategy
    • 17.1.6. Biotronik
      • 17.1.6.1. Overview
      • 17.1.6.2. Product Portfolio
      • 17.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.6.4. Sales Footprint
      • 17.1.6.5. Strategy Overview
        • 17.1.6.5.1. Marketing Strategy
        • 17.1.6.5.2. Product Strategy
        • 17.1.6.5.3. Channel Strategy
    • 17.1.7. Nihon Kohden Corporation
      • 17.1.7.1. Overview
      • 17.1.7.2. Product Portfolio
      • 17.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.7.4. Sales Footprint
      • 17.1.7.5. Strategy Overview
        • 17.1.7.5.1. Marketing Strategy
        • 17.1.7.5.2. Product Strategy
        • 17.1.7.5.3. Channel Strategy
    • 17.1.8. METRAWATT International
      • 17.1.8.1. Overview
      • 17.1.8.2. Product Portfolio
      • 17.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.8.4. Sales Footprint
      • 17.1.8.5. Strategy Overview
        • 17.1.8.5.1. Marketing Strategy
        • 17.1.8.5.2. Product Strategy
        • 17.1.8.5.3. Channel Strategy
    • 17.1.9. Datrend Systems
      • 17.1.9.1. Overview
      • 17.1.9.2. Product Portfolio
      • 17.1.9.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.9.4. Sales Footprint
      • 17.1.9.5. Strategy Overview
        • 17.1.9.5.1. Marketing Strategy
        • 17.1.9.5.2. Product Strategy
        • 17.1.9.5.3. Channel Strategy
    • 17.1.10. Fluke
      • 17.1.10.1. Overview
      • 17.1.10.2. Product Portfolio
      • 17.1.10.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.10.4. Sales Footprint
      • 17.1.10.5. Strategy Overview
        • 17.1.10.5.1. Marketing Strategy
        • 17.1.10.5.2. Product Strategy
        • 17.1.10.5.3. Channel Strategy
    • 17.1.11. BC Group International
      • 17.1.11.1. Overview
      • 17.1.11.2. Product Portfolio
      • 17.1.11.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.11.4. Sales Footprint
      • 17.1.11.5. Strategy Overview
        • 17.1.11.5.1. Marketing Strategy
        • 17.1.11.5.2. Product Strategy
        • 17.1.11.5.3. Channel Strategy
    • 17.1.12. Netech
      • 17.1.12.1. Overview
      • 17.1.12.2. Product Portfolio
      • 17.1.12.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.12.4. Sales Footprint
      • 17.1.12.5. Strategy Overview
        • 17.1.12.5.1. Marketing Strategy
        • 17.1.12.5.2. Product Strategy
        • 17.1.12.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology